TT Pharmacy Registration Exam flashcards
TT Pharmacy Registration Exam · Build recall with a focused review session.
36 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Bioavailability formula
- Absolute bioavailability F = (AUC oral / AUC IV) × (Dose IV / Dose oral). It quantifies the fraction of an administered dose reaching systemic circulation unchanged.
- Half-life equation
- For first-order elimination, t½ = 0.693 / k. Approximately five half-lives are needed to reach about 97% of steady-state plasma concentration.
- Higuchi release model
- Describes drug release from a matrix as proportional to the square root of time (amount ∝ √t). It applies to diffusion-controlled sustained-release systems.
- Biopharmaceutics Classification System
- Classifies drugs by aqueous solubility and intestinal permeability into four classes (I–IV). Class I is high/high; Class IV is low solubility and low permeability.
- Loading dose calculation
- Loading dose = (Vd × target plasma concentration) / F. It rapidly achieves therapeutic levels when the volume of distribution and target concentration are known.
- Therapeutic index
- TI = TD50 / ED50, the ratio of toxic to effective dose. A low index indicates a narrow margin of safety requiring careful monitoring.
- Competitive antagonism effect
- A competitive antagonist shifts the agonist dose–response curve to the right without reducing maximal response. Higher agonist concentrations can overcome the block.
- Zero-order elimination
- A constant amount of drug is eliminated per unit time regardless of concentration. Phenytoin and ethanol are examples; small dose increases can cause toxicity.
- First-pass metabolism
- Hepatic metabolism of an orally absorbed drug before it reaches systemic circulation. It reduces oral bioavailability and is bypassed by IV or sublingual routes.
- Warfarin monitoring
- Warfarin inhibits vitamin K epoxide reductase, reducing clotting factor synthesis. Its effect is monitored with the INR, targeting a range set by indication.
- Lipinski Rule of Five
- Predicts oral drug-likeness: molecular weight ≤500, logP ≤5, hydrogen-bond donors ≤5, acceptors ≤10. Two or more violations suggest poor oral absorption.
- Prodrug concept
- An inactive derivative requiring biotransformation to release the active drug. Enalapril is converted to enalaprilat; codeine is converted to morphine by CYP2D6.
- Phase II metabolism
- Conjugation reactions such as glucuronidation, sulfation, and acetylation that add polar groups. They generally increase water solubility and facilitate excretion.
- Bioisosteric replacement
- Substituting a functional group with a structurally similar one that retains activity. Examples include replacing –COOH with tetrazole to alter pKa and metabolism.
- Enantiomer activity difference
- Enantiomers are mirror-image isomers with different three-dimensional arrangements. They may differ in receptor affinity, potency, and metabolic fate.
- Therapeutic drug monitoring indications
- Used for drugs with narrow therapeutic index and clear concentration–effect relationships, such as digoxin, lithium, vancomycin, and phenytoin.
- SOAP note format
- A structured documentation method with Subjective, Objective, Assessment, and Plan sections. It organizes clinical findings and therapeutic decisions for patient care records.
- Medication reconciliation
- A process of obtaining the best possible medication history, comparing it with current orders, resolving discrepancies, and communicating at care transitions.
- Drug therapy problems
- Categories include indication, effectiveness, safety, and adherence issues. Each requires a specific pharmacist intervention and follow-up plan.
- Alligation method
- Combines two strengths to make a target concentration. The ratio of parts equals (higher % − desired) : (desired − lower %).
- Dilution equation
- C1V1 = C2V2 relates initial and final concentrations and volumes. It is used to calculate the volume of stock solution needed for a dilution.
- IV drip rate
- Drops per minute = (volume in mL × drop factor in gtt/mL) / time in minutes. Common drop factors include 15, 20, and 60 gtt/mL.
- Mosteller body surface area
- BSA (m²) = √[(height in cm × weight in kg) / 3600]. It is used to calculate pediatric and oncology doses based on surface area.
- Sodium chloride equivalent
- The E-value is the amount of NaCl equivalent to 1 g of drug in tonicity. NaCl equivalent = drug weight × E; used to make isotonic solutions.
- Schedule II refill limits
- Schedule II controlled substances generally cannot be refilled without a new prescription. Schedule III–IV products allow limited refills per jurisdiction, commonly five within six months.
- Prescription legal requirements
- A valid prescription includes prescriber identity and license number, patient details, drug name, strength, dosage form, quantity, directions, and date with signature.
- Pharmacist ethical principles
- Core principles include beneficence, non-maleficence, autonomy, justice, veracity, and confidentiality. They guide decisions when duties to patients conflict.
- Generic substitution rule
- Substitution with a bioequivalent generic is generally permitted unless the prescriber prohibits it or the patient refuses. Local law defines specific requirements.
- Cardiac glycoside mechanism
- Digitalis glycosides such as digoxin inhibit Na+/K+-ATPase, increasing intracellular calcium and enhancing cardiac contractility. They have a narrow therapeutic index.
- St John's wort interaction
- St John's wort induces CYP3A4, reducing plasma levels and efficacy of oral contraceptives, warfarin, and some antiretrovirals. It also risks serotonergic interactions.
- Incidence versus prevalence
- Incidence counts new cases in a population at risk over time. Prevalence counts all existing cases in the population at a given point or period.
- Sensitivity and specificity
- Sensitivity = TP/(TP+FN), the ability to detect true disease. Specificity = TN/(TN+FP), the ability to correctly identify those without disease.
- Herd immunity threshold
- Approximated as 1 − 1/R0, where R0 is the basic reproduction number. Higher R0 requires higher vaccination coverage to interrupt transmission.
- Incremental cost-effectiveness ratio
- ICER = (Cost new − Cost old) / (Effect new − Effect old). It expresses the additional cost per additional unit of health outcome gained.
- Economic order quantity
- EOQ = √(2DS/H), where D is annual demand, S is ordering cost, and H is holding cost per unit. It minimizes total ordering and holding costs.
- ABC inventory analysis
- Classifies stock items by annual value, with A items being high-value and few. It prioritizes control efforts on items with the greatest financial impact.